United States Pharmacopoeia (USP) Solutions and Reagents
United States Pharmacopoeia (USP) solutions and reagents are crucial for ensuring the safety, quality, and efficacy of pharmaceuticals in the U.S. market. These products comply with the standards set by the USP and are widely used in drug development and quality control. CymitQuimica offers a comprehensive range of USP-compliant solutions and reagents to support pharmaceutical research and manufacturing.
Found 7646 products of "United States Pharmacopoeia (USP) Solutions and Reagents"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Fosphenytoin Sodium
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormula:C16H13N2Na2O6P·7H2OColor and Shape:White PowderMolecular weight:406.03066Carboplatin
CAS:Inorganic or organic compounds of precious metals, whether or not chemically defined; amalgrams of precious metals, nesoiFormula:C6H12N2O4PtColor and Shape:White PowderMolecular weight:371.0445Methyl 2-chloromethyl-3-nitrobenzoate (methyl 2-(chloromethyl)-3-nitrobenzoate)
CAS:Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives, nesoiFormula:C9H8ClNO4Color and Shape:Off-White PowderMolecular weight:229.01419Bis(dibenzothiazepinyl) Piperazine (1,4-Bis(dibenzo[b,f][1,4]thiazepin-11-yl)piperazine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C30H24N4S2Color and Shape:White SolidMolecular weight:504.14424Denatonium Benzoate
CAS:Aromatic cyclic amides (including cyclic carbamates) anFormula:C21H29N2O·C7H5O2Color and Shape:White Crystalline PowderMolecular weight:446.59Granisetron Hydrochloride
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C18H24N4O·HClColor and Shape:White Off-White PowderMolecular weight:348.17169Caprolactam
CAS:6-hexanelactam (epsilon-caprolactam)Formula:C6H11NOColor and Shape:PowderMolecular weight:113.08406Voriconazole Related Compound F ({(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1-yl}methanesulfonic acid)
CAS:Ketones and quinones, w/not with other oxygen function,and their halogenated,sulfated,nitrated,or nitrosated derivatives, nesoiFormula:C10H16O4SColor and Shape:White PowderMolecular weight:232.07693Digitoxin
CAS:Other glycosides, natural or reproduced by synthesis, and their salts, ethers, esters and other derivativesFormula:C41H64O13Color and Shape:White Off-White Crystalline PowderMolecular weight:764.94 g/molAmrinone Related Compound C (6-Oxo-1,6-dihydro-[3,4'-bipyridine]-5-carbonitrile)
CAS:Lactams, nesoiFormula:C11H7N3OColor and Shape:Tan Off-White PowderMolecular weight:197.05891Ethylcellulose
CAS:Cellulose ethers,nesoiFormula:C23H24N6O4Color and Shape:PowderMolecular weight:448.4745Candesartan Cilexetil Related Compound D (1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-({2'-(2-ethyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl}methyl)-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C33H34N6O6Color and Shape:White PowderMolecular weight:610.25398Ethylhexyl Acetate (2-Ethyl-1-hexanol acetate)
CAS:Esters of acetic acid, nesoiFormula:C10H20O2Color and Shape:Colorless LiquidMolecular weight:172.14633Fexofenadine Olefin (2-(4-(4-(4-(diphenylmethylene)piperidin-1-yl)-1-hydroxybutyl)phenyl)-2-methylpropanoic acid)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C32H37NO3Color and Shape:White Off-White SolidMolecular weight:483.27734Famotidine Related Compound F (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanoic acid)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C8H12N4O2S2Color and Shape:White PowderMolecular weight:260.040171,4-Butanedisulfonic Acid
CAS:Hydrocarbon derivatives containing only sulfo groups, their salts andestersFormula:C4H10O6S2Color and Shape:White PowderMolecular weight:217.99188Triprolidine Hydrochloride Z-Isomer
Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C19H22N2·HClColor and Shape:White Crystalline PowderMolecular weight:278.1783Alosetron Hydrochloride (2,3,4,5-Tetrahydro-5-methyl-2-[(5-methylimidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one hydrochloride)
CAS:Lactams not elsewhere specified or includedFormula:C17H18N4O·HClColor and Shape:White Beige SolidMolecular weight:330.1247411-Deoxy Prednisolone (17,21-Dihydroxypregna-1,4-diene-3,20-dione)
CAS:Ketone-alcohols and ketone-aldehydes, nesoiFormula:C21H28O4Color and Shape:White PowderMolecular weight:344.19876Daidzin
CAS:Other glycosides, natural or reproduced by synthesis, and their salts, ethers, esters and other derivativesFormula:C21H20O9Color and Shape:White Off-White PowderMolecular weight:416.11073Amlodipine Morpholine Analog (5-Ethyl 7-methyl 6-(2-chlorophenyl)-3,4,6,7-tetrahydro-8-methyl-2H-1,4-benzoxazine-5,7-dicarboxylate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C20H22ClNO5Molecular weight:391.11865Cromolyn Sodium
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C23H14Na2O11Color and Shape:White Crystalline PowderMolecular weight:512.03315Tadalafil
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H19N3O4Color and Shape:White Off-White PowderMolecular weight:389.13756Hydroxyindolinonylalanine ((2S)-2-Amino-3-(3-hydroxy-2-oxoindolin-3-yl)propanoic acid)
CAS:Lactams, nesoiFormula:C11H12N2O4Color and Shape:Off-White SolidMolecular weight:236.079712-Chloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-(2-chlorophenyl)propan-1-one hydrochloride)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormula:C13H18ClNO·HClColor and Shape:White PowderMolecular weight:275.08437Sumatriptan
CAS:Sulfonamides used as drugsFormula:C14H21N3O2SColor and Shape:White Off-White PowderMolecular weight:295.13545Moexipril Related Compound D ((S)-2-{(S)-2-[(S)-4-cyclohexyl-1-ethoxy-1-oxobutan-2-ylamino]propanoyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormula:C27H40N2O7·HClColor and Shape:Beige PowderMolecular weight:504.28355Artemether Related Compound B ((3R,5aS,6R,8aS,9R,10R,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin)
CAS:Heterocyclic compounds with oxygen hetero-atom(s) onlyFormula:C16H26O5Color and Shape:White Solid PowderMolecular weight:298.17802Rufinamide Related Compound B (Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate)
CAS:Aromatic or modified aromatic heterocyclic compounds wiFormula:C11H9F2N3O2Color and Shape:White PowderMolecular weight:253.06628Clonidine Related Compound A (1-Acetyl-2-(2,6-dichlorophenylimino)-imidazolidine)
CAS:Compounds containing an unfused imidazole ring (whetherFormula:C11H11Cl2N3OColor and Shape:White PowderMolecular weight:271.02792Olanzapine Related Compound B (2-methyl-10H-thieno-[2,3-b][1,5]benzodiazepin-4[5H]-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C12H10N2OSColor and Shape:Pale Yellow Dark Yellow PowderMolecular weight:230.05138Pimozide
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C28H29F2N3OColor and Shape:Colorless Beige PowderMolecular weight:461.22787Aprepitant Related Compound A (3-[[(2R,3R)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C23H21F7N4O3Color and Shape:White Off-White PowderMolecular weight:534.15019Eucalyptol
CAS:Heterocyclic compounds with oxygen hetero-atom(s) onlyFormula:C10H18OColor and Shape:LiquidMolecular weight:154.25 g/molHeparin Sodium System Suitability
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:PowderPrazosin Hydrochloride
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H21N5O4·HClColor and Shape:White Tan Crystalline PowderMolecular weight:419.13603Dimethyl Fumarate Related Compound A ((E)-4-Methoxy-4-oxobut-2-enoic acid)
CAS:Acyclic polycarboxylic acids and their anhydrides, halides, peroxides and their derivatives, nesoiFormula:C5H6O4Color and Shape:White PowderMolecular weight:130.02661Clenbuterol Related Compound B (1-(4-amino-3,5-dichlorophenyl)-2-tert-butylaminoethanone hydrochloride)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormula:C12H16Cl2N2O·HClColor and Shape:Off-White Crystalline PowderMolecular weight:274.06397Oleyl Oleate 95
CAS:Salts and esters of oleic, linoleic, or linolenic acids, nesoiFormula:C36H68O2Color and Shape:Clear Colorless LiquidMolecular weight:532.52193Ureidolacosamide ((R)-N-Benzyl-2-(3-benzylureido)-3-methoxypropanamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C19H23N3O3Color and Shape:White SolidMolecular weight:341.17394Stearyl Alcohol
CAS:Dodecan-1-ol (lauryl alcohol), hexadecan-1-ol (cetyl alcohol), and octadecan-1-ol (stearyl alcohol)Formula:C18H38OColor and Shape:White FlakesMolecular weight:270.29227Methylphenidate Related Compound A (α-Phenyl-2-piperidineacetic Acid Hydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C13H17NO2·HClColor and Shape:White PowderMolecular weight:255.10261Krill Oil
CAS:Fatty substances animal/veg origin & mixtures nesoiColor and Shape:Dark Red Viscous Oily LiquidDiethylcarbamazine Citrate
CAS:Drugs containing a pyrimidine ring (whether or not hydrFormula:C16H29N3O8Color and Shape:PowderMolecular weight:391.4 g/molIdoxuridine
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C9H11IN2O5Color and Shape:White Crystalline PowderMolecular weight:353.97127Molindone Related Compound A (3-Ethyl-2-methyl-1,5,6,7-tetrahydro-4H-indol-4-one)
CAS:Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFormula:C11H15NOColor and Shape:Off-White PowderMolecular weight:177.25 g/molN-Nitroso Edoxaban (N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-nitroso-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C23H27ClN8O5SColor and Shape:Off-White SolidMolecular weight:563.03Phenylbutyrate Related Compound A (4-oxo-4-phenylbutanoic acid)
CAS:Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFormula:C10H10O3Color and Shape:PowderMolecular weight:178.06299
![Voriconazole Related Compound F ({(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1-yl}methanesulfo…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1718063.webp&w=3840&q=75)
![Olanzapine Related Compound B (2-methyl-10H-thieno-[2,3-b][1,5]benzodiazepin-4[5H]-one)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1478323.webp&w=3840&q=75)
